ArticleScientific reports2019
Dual targeting of IGF-1R and ErbB3 as a potential therapeutic regimen for ovarian cancer.
Adam J Camblin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ArticleScientific reports2019
Adam J Camblin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.